Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/03/2012EP2503989A2 Topical foam composition
10/03/2012EP2503988A2 Topical foam composition
10/03/2012EP2503891A1 Pyrimidine ether derivatives and methods of use thereof
10/03/2012EP2503890A1 Azabenzimidazoles as fatty acid synthase inhibitors
10/03/2012EP2503888A1 Cyclodextrin-based polymers for therapeutic delivery
10/03/2012EP2503881A1 Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
10/03/2012CN1993318B Bis(thio-hydrazide amide) salts for treatment of cancers
10/03/2012CN1988923B Bone substitute compositions and method of use
10/03/2012CN1915233B Medicine composition for treating anxiety neurosis, and oral cavity disintegration preparation
10/03/2012CN1869048B Method of extracting and separating F group ginseng saponin from ginseng leaf
10/03/2012CN1791401B Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
10/03/2012CN1759176B Diagnosis and treatment of multiple sulfatase deficiency andother sulfatase deficiencies using a formylglycine generating enzyme (FGE)
10/03/2012CN1638787B Helicobacter pylori adhesion inhibitor
10/03/2012CN1424875B Method of controlling zoological and aquatic plant growth
10/03/2012CN102712935A Nucleic acid-containing lipid particles and related methods
10/03/2012CN102712928A Antisense antiviral compound and method for treating influenza viral infection
10/03/2012CN102712927A Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1
10/03/2012CN102712925A Treatment of SIRTUIN (SIRT) related diseases by inhibition of natural antisense transcript to a SIRTUIN (SIRT)
10/03/2012CN102712924A Combination of a chemotherapeutic agent and an inhibitor of the TGF-[beta] system
10/03/2012CN102712672A Polyhydroxylated bile acids for treatment of biliary disorders
10/03/2012CN102712658A N-containing heteroaryl derivatives as jak3 kinase inhibitors
10/03/2012CN102712657A Antimicrobial compounds and methods of making and using the same
10/03/2012CN102712656A 2,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors
10/03/2012CN102712653A Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof
10/03/2012CN102712650A Spiro-oxindole MDM2 antagonists
10/03/2012CN102712648A Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls
10/03/2012CN102712647A Antimicrobial compounds and methods of making and using the same
10/03/2012CN102712646A RAF inhibitor compounds and methods of use thereof
10/03/2012CN102712645A Compounds
10/03/2012CN102712644A Novel macrocyclic inhibitors of hepatitis C virus replication
10/03/2012CN102712643A Modulators of 5-HT receptors and methods of use thereof
10/03/2012CN102712642A N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use
10/03/2012CN102712641A MK2 inhibitors
10/03/2012CN102712640A Tricyclic heterocyclic compounds, compositions and methods of use thereof
10/03/2012CN102712638A New phenylhydrazone derivatives and their use as pharmaceuticals
10/03/2012CN102712636A Compounds and compositions as TLR activity modulators
10/03/2012CN102712635A 1h-pyrazolo [3,4-b] pyridine compounds for inhibiting RAF kinase
10/03/2012CN102712633A Inhibitors of flaviviridae viruses
10/03/2012CN102712632A Inhibitors of flaviviridae viruses
10/03/2012CN102712629A An amorphous and a crystalline form of Genz 112638 hemitartrat as inhibitor of glucosylceramide synthase
10/03/2012CN102712628A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
10/03/2012CN102712626A Piperazine compound having a PGDS inhibitory effect
10/03/2012CN102712625A Nitrogen-containing heteroaryl derivatives
10/03/2012CN102712624A Indole compound and pharmaceutical use thereof
10/03/2012CN102712623A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
10/03/2012CN102712622A Indole derivative modulators of the alpha 7 nAChR
10/03/2012CN102712621A Pyrazine derivatives and their use in the treatment of neurological disorders
10/03/2012CN102712620A 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds
10/03/2012CN102712619A 5-hydroxypyrimidine-4-carboxamide derivative
10/03/2012CN102712618A Novel compounds as receptor modulators with therapeutic utility
10/03/2012CN102712615A Chromenone derivatives with anti-tumour activity
10/03/2012CN102712610A Novel 3-hydroxy-5-arylisothiazole derivative
10/03/2012CN102712609A 2-Amino-5,5-difluoro-5,6-dihydro-4h-oxazines as BACE1 and/or BACE2 inhibitors
10/03/2012CN102712607A Novel compounds as receptor modulators with therapeutic utility
10/03/2012CN102712605A Process to make UV radiation absorbing 2 - phenyl - 1, 2, 3 - benzotriazoles
10/03/2012CN102712604A Sulfoxide derivatives for treating tumors
10/03/2012CN102712601A A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
10/03/2012CN102712597A Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
10/03/2012CN102712596A New secondary 8-hydroxyquinoline-7-carboxamide derivatives
10/03/2012CN102712595A Novel compositions for reducing A beta 42 production and their use in treating alzheimer's disease (AD)
10/03/2012CN102712594A Phenol derivatives and pharmaceutical or cosmetic use thereof
10/03/2012CN102712591A Fluorinated derivatives of 3-hydroxypyridin-4-ones
10/03/2012CN102712589A Aryl-pyridine derivatives as aldosterone synthase inhibitors
10/03/2012CN102712587A Novel ethane diamine hepcidin antagonists
10/03/2012CN102712584A 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof
10/03/2012CN102712577A Substituted 3-phenylpropionic acids and the use thereof
10/03/2012CN102712575A Homoglutamic acid derivatives
10/03/2012CN102712552A Method for production of F-18 labeled glutamic acid derivatives
10/03/2012CN102711916A Use of an adrenal hormone-modifying agent
10/03/2012CN102711841A Iodine-labeled homoglutamic acid and glutamic acid derivatives
10/03/2012CN102711835A Topical ibuprofen formulations
10/03/2012CN102711834A Implantable devices for treating HIV
10/03/2012CN102711831A Antibacterial oral composition
10/03/2012CN102711800A Composition and method for treatment of diabetes
10/03/2012CN102711798A Pharmaceutical compositions for the stimulation of stem cells
10/03/2012CN102711796A Application and uses of PRG4 and therapeutic modulation thereof
10/03/2012CN102711787A PAR1 antagonists for use in the treatment or prevention of influenza virus type A infections
10/03/2012CN102711784A Composition and method for improving vascular health
10/03/2012CN102711780A Preparation comprising amino acids and plants and its activity in alcohol detoxification
10/03/2012CN102711774A Composition for preventing and treating obesity diseases containing highly water-soluble 2-hydroxypropyl-[beta]-cyclodextrin as active ingredient
10/03/2012CN102711773A Inhibitors for growth hormone and related hormones, and methods of use thereof
10/03/2012CN102711772A Anti-neoplastic uses of artemin antagonists
10/03/2012CN102711771A Combination, kit and method of reducing intraocular pressure
10/03/2012CN102711770A Cerebral nerve cell neogenesis agent
10/03/2012CN102711769A Use of steroid compounds for inflammatory and autoimmune disorders
10/03/2012CN102711768A Compositions and methods for the prevention and treatment of heart failure
10/03/2012CN102711767A Certain chemical entities, compositions and methods
10/03/2012CN102711766A N-9-substituted purine compounds, compositions and methods of use
10/03/2012CN102711765A Kinase inhibitors
10/03/2012CN102711764A Synthesis of a neurostimulative piperazine
10/03/2012CN102711763A Pharmaceutical composition for oral administration
10/03/2012CN102711762A Solid pharmaceutical composition for oral administration
10/03/2012CN102711761A Elution-stabilized preparation
10/03/2012CN102711760A Use of aerosolized antibiotics for treating chronic obstructive pulmonary disease
10/03/2012CN102711759A Therapeutic or prophylactic agent for biliary diseases
10/03/2012CN102711758A 5-(1H-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eye
10/03/2012CN102711757A Methods and assays for the treatment of irritable bowel syndrome
10/03/2012CN102711756A Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
10/03/2012CN102711755A Pharmaceutical composition for peroral administration of 3,3'-diindolylmethane
10/03/2012CN102711754A Method for preparing hollow particles, and uses thereof
1 ... 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 ... 7860